ArticleJournal of physical therapy science2016
Zhoubo plus uncaria tincture in the treatment of cerebral concussion sequelae.
Article in Journal of physical therapy science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
[Purpose] This study investigated the clinical efficacy of the compound gouteng tincture combined with Zhoubo (GT-ZB) in treating the sequelae of cerebral concussion (CC) in children. [Subjects and Methods] Sixty children with CC-sequelae were randomily divided into a treatment group and a control group, with 30 cases in each group. The treatment group was treated using GT-ZB, and the control group was treated using the standard method of venoruton, dibazol, and Vitamin B6. The efficacies of the two treatments were compared. [Results] Compared with the control group, the clinical symptoms and signs in the treatment group were significantly mitigated. [Conclusion] GT-ZB demonstrated efficacy in treating the sequelae of CC in children, and it is worthy of further studies and possible clinical recommendations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.